The Corona Control Task Force, in which Professor Imoto participates as a core member, has built Asia's largest biorepository and elucidated the mechanism of exacerbation of the COVID-19 disease susceptibility gene DOCK2. This result will lead to a new therapeutic target for COVID-19. The paper was published in Nature.
Nature has published the results of its contribution to the COVID-19 Host Genetics Initiative, an international collaborative research group, as a task force to control the corona. We are analyzing gene polymorphisms involved in the aggravation of COVID-19.
A paper on the clinical trial of the cholera vaccine MucoRice-CTB has been published in the Lancet Microbe.
We analyzed the intestinal bacteria associated with vaccine efficacy. This is a joint research project with Prof. Kiyono.
The Institute of Medical Science, The University of Tokyo and IBM jointly developed a SARS-CoV-2 genome analysis and visualization system to reduce the risk of spread of COVID-19 in Japan
A paper examining the infection risk at the opening ceremony of the Tokyo Olympic Games 2020 and the effects of various countermeasures by simulation was published in the international scientific journal Microbial Risk Analysis of microbial infection risk analysis.
October 14, 2020
The results of our joint research with Fujitsu Laboratories are being used to create "JDream SR", an article research service that utilizes AI.